Evidence map›Paper›PMID 38751870›Full record

ArticleIranian journal of medical sciences2024

The Emergence of Linezolid-Resistant

Roya Sadidi, Hatef Ajoudanifar, Hamed Ghasem Zadeh-Moghadam, Amir Azimian

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Iranian journal of medical sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Roya SadidiDepartment of Biology, College of Basic Sciences, Damghan Branch, Islamic Azad University, Damgan, Iran.
Hatef AjoudanifarDepartment of Biology, College of Basic Sciences, Damghan Branch, Islamic Azad University, Damgan, Iran.
Hamed Ghasem Zadeh-MoghadamDepartment of Pathobiology and Laboratory Sciences, Faculty of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran.
Amir AzimianDepartment of Pathobiology and Laboratory Sciences, Faculty of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present study aimed to investigate secondary bacterial infections among patients infected with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Coagulase-negative Staphylococci can infect immunocompromised patients. Linezolid resistance among

Indexed as

COVID-19LinezolidStaphylococcal InfectionsStaphylococcus epidermidisAdultAgedAnti-Bacterial AgentsCoinfectionDrug Resistance, BacterialFemaleHumansIranMaleMicrobial Sensitivity TestsMiddle AgedSARS-CoV-2Anti-Bacterial AgentsLinezolidCOVID-19Drug resistanceMicrobial, linezolidStaphylococcus epidermidisVancomycin

Identifiers

PMID38751870
PMCPMC11091267

What OpenQuestion holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.